Tumor treating fields: Concept, evidence and future

Expert Opinion on Investigational Drugs

Volumn 20, Issue 8, 2011, Pages 1099-1106

  Pless, Miklos ^a,b,c   Weinberg, Uri ^d  

^a Medical Oncology   (Switzerland)

^b Tumor Center   (Switzerland)

^c CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

^d Novocure GmbH   (Israel)

Author keywords

Cancer; Electric fields; Glioblastoma; Non small cell lung cancer; TTFields

Indexed keywords

ANTINEOPLASTIC AGENT; PEMETREXED;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CANCER THERAPY; CLINICAL TRIAL (TOPIC); ELECTRIC FIELD; GLIOBLASTOMA; HUMAN; LUNG NON SMALL CELL CANCER; MITOSIS; MITOSIS SPINDLE; MONOTHERAPY; NONHUMAN; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; REVIEW; TUMOR; TUMOR TREATING FIELD;

ANIMALS; CLINICAL TRIALS AS TOPIC; ELECTRIC STIMULATION THERAPY; ELECTRODES; ELECTROMAGNETIC FIELDS; HUMANS; NEOPLASMS;

EID: 79960360550     PISSN: 13543784     EISSN: 17447658     Source Type: Journal    
DOI: 10.1517/13543784.2011.583236     Document Type: Review

References (31)

1. Polk C. Therapeutic applications of low-frequency sinusoidal and pulsed electric and magnetic fields. In: Bronzino JD, editor, The biomedical engineering handbook. CRC Press, Inc., Boca Raton, FL; 1995. p. 1404-16
2. Stimulation of internal organs by means of externally applied electrodes. Palti Y J Appl Physiol 1966;21(5):1619-12
3. Bassett CA. The development and application of pulsed electromagnetic fields (PEMFs) for ununited fractures and arthrodeses. Clin Plast Surg 1985;20:259-77 (Pubitemid 15147320)
4. Elson E. Biologic effects of radiofrequency and microwave fields: in vivo and in vitro experimental results. In: Bronzino JD, editor, The biomedical engineering handbook. CRC Press, Inc., Boca Raton, FL; 1995. p. 1417-23
5. Chou CK. Radiofrequency hyperthermia in cancer therapy. In: Bronzino JD, editor. The biomedical engineering handbook. CRC Press, Inc., Boca Raton, FL; 1995. p. 1424-30
6. Goater AD, Pethig R. Electrorotation and dielectrophoresis. Parasitology 1998;117(Suppl):S177-89
7. Sowers AE. Characterization of electric field-induced fusion in erythrocyte ghost membranes. J Cell Biol 1986;102(4):1358-62
8. Takashima S, Schwan HP. Alignment of microscopic particles in electric fields and its biological implications. Biophys J 1985;47(4):513-18
9. Maier H. Electrorotation of colloidal particles and cells depends on surface charge. Biophys J 1997;73(3):1617-26 (Pubitemid 27360750)
10. Clague DS, Wheeler EK. Dielectrophoretic manipulation of macromolecules: the electric field. Phys Rev E Stat Nonlin Soft Matter Phys 2001;64(2 Pt 2):026605
11. Gonzalez CF, Remcho VT. Harnessing dielectric forces for separations of cells, fine particles and macromolecules. J Chromatogr A 2005;1079(1-2):59-68 (Pubitemid 40813187)
12. Kirson ED, Gurvich Z, Schneiderman R, et al. Disruption of cancer cell replication by alternating electric fields. Cancer Res 2004;64(9):3288-95 (Pubitemid 38581435)
13. Kirson ED, Dbaly V, Tovarys F, et al. Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors. Proc Natl Acad Sci USA 2007;104(24):10152-7 (Pubitemid 47175278)
14. Kirson ED, Schneiderman RS, Dbaly V, et al. Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields). BMC Med Phys 2009;9:1
15. Kirson ED, Giladi M, Gurvich Z, et al. Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungs. Clin Exp Metastasis 2009;26(7):633-40
16. Stupp R, Kanner A, Engelhard H, et al. A prospective, randomized, open-label, phase III clinical trial of NovoTTFields-100A versus best standard of care chemotherapy in patients with recurrent glioblastoma. J Clin Oncol 2010;28(18S):abstract LBA2007
17. Ram Z, Gutin PH, Stupp R. Subgroup and quality of life analyses of the phase III clinical trial of NovoTTFields-100A versus best standard chemotherapy for recurrent glioblastoma. Neuro Oncol 2010;12(Suppl 4):iv36-iv57
18. Pless M, Betticher DC, Buess M, et al. A phase II study of tumor-treating fields (TTFields) in combination with pemetrexed for advanced non-small cell lung cancer (NSCLC) abstract 371PD]. ESMO; 2010
19. Hanna N, Shepherd FA, Fossella FV, et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 2004;22(9):1589-97 (Pubitemid 41079796)
20. Webster JG, Clark JW. Medical Instrumentation: application and design. Wiley, New York; 1998
21. Burnette RR, Ongpipattanakul B. Characterization of the pore transport properties and tissue alteration of excised human skin during iontophoresis. J Pharm Sci 1988;77(2):132-7 (Pubitemid 18043957)
22. Orrenius S, McCabe MJ Jr, Nicotera P. Ca(2+)-dependent mechanisms of cytotoxicity and programmed cell death. Toxicol Lett 1992;64-65 Spec No:357-64
23. Schneiderman RS, Shmueli E, Kirson ED, Palti Y. TTFields alone and in combination with chemotherapeutic agents effectively reduce the viability of MDR cell sub-lines that over-express ABC transporters. BMC Cancer 2010;10:229
24. Leonard CE, Chan DC, Chou TC, et al. Paclitaxel enhances in vitro cell lines of the head and neck. Cancer Res 1996;56(22):5198-204
25. Novello S, Le Chevalier T. Use of chemo-radiotherapy in locally advanced non-small cell lung cancer. Eur J Cancer 2002;38(2):292-9 (Pubitemid 34137003)
26. Choy H, Kim DW. Chemotherapy and irradiation interaction. Semin Oncol 2003;30(4 Suppl 9):3-10 (Pubitemid 36999672)
27. Stewart TJ, Greeneltch KM, Lutsiak ME, Abrams SI. Immunological responses can have both pro- and antitumour effects: implications for immunotherapy. Expert Rev Mol Med 2007;9(4):1-20 (Pubitemid 46242913)
28. Salzberg M, Kirson E, Palti Y, Rochlitz C. A pilot study with very low-intensity, intermediate-frequency electric fields in patients with locally advanced and/or metastatic solid tumors. Onkologie 2008;31(7):362-5 (Pubitemid 351967572)
29. Dong H, Luo L, Hong S, et al. Integrated analysis of mutations, miRNA and mRNA expression in glioblastoma. BMC Syst Biol 2010;4:163
30. Sjostrom S, Andersson U, Liu Y, et al. Genetic variations in EGF and EGFR and glioblastoma outcome. Neuro Oncol 2010;12(8):815-21
31. Lee W, Jiang Z, Liu J, et al. The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 2010;465(7297):473-7